FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3186453430> ?p ?o ?g. }

• W3186453430 endingPage "103379" @default.
• W3186453430 startingPage "103379" @default.
• W3186453430 abstract "Hepatitis C (HCV) infection is prevalent in the prison setting, with sharing of unsterile injecting equipment the most common mode of transmission in high income countries. Mathematical modelling suggests that HCV treatment scale-up could prevent onward transmission, known as treatment as prevention. Direct-acting antivirals have enabled rapid scale up of HCV treatment, underpinning the first clinical trial of treatment as prevention in the prison setting. The Surveillance and Treatment of Prisoners with hepatitis C (SToP-C) study was carried out in four correctional centres in New South Wales, Australia. This paper utilises Sekhon's Theoretical Framework of Acceptability to examine correctional, prison health, and study personnel's assessments of acceptability of HCV treatment as prevention in the prison setting.Correctional (n=24) and health personnel (n=17) including officers, nurses (including seven study nurses), and senior administrators across the four prisons where SToP-C was delivered, participated in interviews. This included two maximum security, one minimum security, and one women's medium/minimum security prison. Data analysis was informed by a seven-component theory of acceptability.Participants reported broad acceptability of HCV treatment as prevention in the prison setting across five components of acceptability (affective attitude, burden, ethicality, perceived effectiveness, and self-efficacy). Attributes contributing to acceptability included reduced HCV prevalence within the prison, and public health benefits for the community when people are released without HCV (affective attitude). Elements which may negatively impact on acceptability included limited clinic space (burden) and lack of correctional officers' understanding of availability of equivalent healthcare in the community (ethicality). System-wide prison participation was viewed as necessary for treatment as prevention to be successful (perceived effectiveness), while nonjudgmental care was seen as instrumental to HCV treatment scale up efforts (self-efficacy).Correctional and prison-based health personnel view HCV treatment as prevention as an acceptable health intervention. Overall, environmental issues relating to implementation (i.e., clinic space) were viewed as requiring a strategic approach to support prison-wide HCV treatment scale up." @default.
• W3186453430 created "2021-08-02" @default.
• W3186453430 creator A5004304607 @default.
• W3186453430 creator A5036094994 @default.
• W3186453430 creator A5042369304 @default.
• W3186453430 creator A5045529959 @default.
• W3186453430 creator A5051184153 @default.
• W3186453430 creator A5052909853 @default.
• W3186453430 date "2021-12-01" @default.
• W3186453430 modified "2023-10-16" @default.
• W3186453430 title "Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel" @default.
• W3186453430 cites W1096537867 @default.
• W3186453430 cites W1979985621 @default.
• W3186453430 cites W1989454135 @default.
• W3186453430 cites W1998667681 @default.
• W3186453430 cites W2024132711 @default.
• W3186453430 cites W2059950149 @default.
• W3186453430 cites W2061585289 @default.
• W3186453430 cites W2090165831 @default.
• W3186453430 cites W2101253644 @default.
• W3186453430 cites W2119401222 @default.
• W3186453430 cites W2143718001 @default.
• W3186453430 cites W2146562532 @default.
• W3186453430 cites W2150326904 @default.
• W3186453430 cites W2281670772 @default.
• W3186453430 cites W2403969263 @default.
• W3186453430 cites W2469883028 @default.
• W3186453430 cites W2473174975 @default.
• W3186453430 cites W2522309098 @default.
• W3186453430 cites W2578013986 @default.
• W3186453430 cites W2582406074 @default.
• W3186453430 cites W2591797736 @default.
• W3186453430 cites W2593728786 @default.
• W3186453430 cites W2602169852 @default.
• W3186453430 cites W2765561710 @default.
• W3186453430 cites W2786754429 @default.
• W3186453430 cites W2884426912 @default.
• W3186453430 cites W2888082412 @default.
• W3186453430 cites W2904957920 @default.
• W3186453430 cites W2905303564 @default.
• W3186453430 cites W2916043652 @default.
• W3186453430 cites W2944204627 @default.
• W3186453430 cites W2947905863 @default.
• W3186453430 cites W3000839250 @default.
• W3186453430 cites W3010465764 @default.
• W3186453430 cites W3032453201 @default.
• W3186453430 cites W3090691701 @default.
• W3186453430 cites W3092644869 @default.
• W3186453430 cites W3134780744 @default.
• W3186453430 cites W3160551159 @default.
• W3186453430 doi "https://doi.org/10.1016/j.drugpo.2021.103379" @default.
• W3186453430 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34311138" @default.
• W3186453430 hasPublicationYear "2021" @default.
• W3186453430 type Work @default.
• W3186453430 sameAs 3186453430 @default.
• W3186453430 citedByCount "2" @default.
• W3186453430 countsByYear W31864534302022 @default.
• W3186453430 crossrefType "journal-article" @default.
• W3186453430 hasAuthorship W3186453430A5004304607 @default.
• W3186453430 hasAuthorship W3186453430A5036094994 @default.
• W3186453430 hasAuthorship W3186453430A5042369304 @default.
• W3186453430 hasAuthorship W3186453430A5045529959 @default.
• W3186453430 hasAuthorship W3186453430A5051184153 @default.
• W3186453430 hasAuthorship W3186453430A5052909853 @default.
• W3186453430 hasConcept C118552586 @default.
• W3186453430 hasConcept C119599485 @default.
• W3186453430 hasConcept C121332964 @default.
• W3186453430 hasConcept C127413603 @default.
• W3186453430 hasConcept C138816342 @default.
• W3186453430 hasConcept C142462285 @default.
• W3186453430 hasConcept C15744967 @default.
• W3186453430 hasConcept C159047783 @default.
• W3186453430 hasConcept C159110408 @default.
• W3186453430 hasConcept C2776455275 @default.
• W3186453430 hasConcept C2777931914 @default.
• W3186453430 hasConcept C2778755073 @default.
• W3186453430 hasConcept C2780656516 @default.
• W3186453430 hasConcept C2993143319 @default.
• W3186453430 hasConcept C3013748606 @default.
• W3186453430 hasConcept C512399662 @default.
• W3186453430 hasConcept C62520636 @default.
• W3186453430 hasConcept C71924100 @default.
• W3186453430 hasConcept C73484699 @default.
• W3186453430 hasConcept C761482 @default.
• W3186453430 hasConceptScore W3186453430C118552586 @default.
• W3186453430 hasConceptScore W3186453430C119599485 @default.
• W3186453430 hasConceptScore W3186453430C121332964 @default.
• W3186453430 hasConceptScore W3186453430C127413603 @default.
• W3186453430 hasConceptScore W3186453430C138816342 @default.
• W3186453430 hasConceptScore W3186453430C142462285 @default.
• W3186453430 hasConceptScore W3186453430C15744967 @default.
• W3186453430 hasConceptScore W3186453430C159047783 @default.
• W3186453430 hasConceptScore W3186453430C159110408 @default.
• W3186453430 hasConceptScore W3186453430C2776455275 @default.
• W3186453430 hasConceptScore W3186453430C2777931914 @default.
• W3186453430 hasConceptScore W3186453430C2778755073 @default.
• W3186453430 hasConceptScore W3186453430C2780656516 @default.
• W3186453430 hasConceptScore W3186453430C2993143319 @default.

• next